Fosinopril-HCT-Mepha 20 mg/12.5 mg, Tabletten

7680583240043 CH-58324 Tabletten
Fosinopril-HCT-Mepha 20 mg/12.5 mg, Tabletten
Fosinopril-HCT-Mepha 20 mg/12.5 mg, Tabletten
Fosinopril-HCT-Mepha 20 mg/12.5 mg, Tabletten
1 / 3
google

Article details

Package size
98
Selling units
98
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
fosinoprilum natricum
20.0 MG Substance Wirkstoff (Principe actif)
hydrochlorothiazidum
12.5 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
222.1 MG Substance HBESI
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
amylum pregelificatum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
glyceroli dibehenas
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
58324
Drug name
Fosinopril-HCT-Mepha, Tabletten
Galenic form
TAB
ATC Code
C09BA09
Authorization status
Revoked/Withdrawn
Dispensing category
B
First authorization
15/09/2008
Authorization expiration date
01/12/2025
IT Number
02.07.2.
Domain
Human medicine
Field of application
Antihypertensivum

Package details

Description (FR)
FOSINOPRIL-HCT Mepha cpr 20/12.5 mg 98 pce
Description (DE)
FOSINOPRIL-HCT Mepha Tabl 20/12.5 mg 98 Stk
Market launch
15/09/2008
Market withdrawal
15/07/2025
Narcotic (BTM)
No

Other package sizes (3)

None
None None
GTIN: None
Not in V1
FOSINOPRIL-HCT Mepha cpr 20/12.5 mg 28 pce
28 TABL
GTIN: 7680583240029
View
None
None None
GTIN: None
Not in V1
Buy us a coffee Explore the data